Download PDF
Semin Liver Dis 2003; 23(1): 005-020
DOI: 10.1055/s-2003-37587
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

The Hepatitis B Virus and Common Mutants

Stephen Locarnini1 , Janine McMillan2 , Angeline Bartholomeusz2
  • 1Professor, Victorian Infectious Diseases Reference Laboratory
  • 2Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia
Further Information

Publication History

Publication Date:
03 March 2003 (online)

    Permissions and Reprints

ABSTRACT

Most biological systems have developed complex mechanisms to maintain the stability of their genetic information. Exceptions to this include viruses that can undergo rapid and substantial genetic sequence changes and alterations. The hepatitis B virus (HBV) has evolved a unique life cycle resulting in the production of enormous viral loads during active replication without actually directly killing the infected cell. Because the virus uses reverse transcription to copy its DNA genome, mutant viral genomes are frequently found. Particular selection pressures, both endogenous (host immune clearance) and exogenous (vaccines and antivirals), readily select out these escape mutants. It is still not known which particular viral mutations or combination of mutations directly affects the clinical presentation of the liver disease, the nature of the viral persistence, or the course and outcome of chronic infection. Further studies are needed to identify the pathogenic basis for the selection of these mutants. Such research should help improve the basic understanding of this unique virus-host relationship and provide new strategies for complete control of HBV infections.

KEYWORDS

Reverse transcription - covalently closed circular DNA - viral mutants - drug resistance - vaccine escape

REFERENCES

  • 1 Chisari F, Ferrari C. Hepatitis B virus immunopathogenesis.  Annu Rev Immunol . 1995;  13 29-60
    CrossrefPubMedGoogle Scholar
  • 2 Ganem D, Schneider R. Hepadnaviridae: the viruses and their replication. In: Knipe DM, Howley PM, eds. Fields Virology Philadelphia: Lippincott-Raven 2001: 2923-2970
    Google Scholar
  • 3 Kann M, Gerlich W. Hepadnaviridae: structure and molecular virology. In: Zuckerman A, Thomas H, eds. Viral Hepatitis London: Churchill Livingstone 1998: 77-105
    Google Scholar
  • 4 Stuyver L, De Gendt S, Van Geyt C. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness.  J Gen Virol . 2000;  81 67-74
    PubMedGoogle Scholar
  • 5 Kao J H. Clinical relevance of hepatitis B viral genotypes: a case of déjà vu?.  J Gastroenterol Hepatol . 2002;  17 113-115
    CrossrefPubMedGoogle Scholar
  • 6 Funk M L, Rosenberg D M, Lok A S. World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants.  J Viral Hepat . 2002;  9 52-61
    CrossrefPubMedGoogle Scholar
  • 7 Kao J H. Hepatitis B viral genotypes: clinical relevance and molecular characteristics.  J Gastroenterol Hepatol . 2002;  17 643-650
    CrossrefPubMedGoogle Scholar
  • 8 Kao J H, Liu C J, Chen D S. Hepatitis B viral genotypes and lamivudine resistance.  J Hepatol . 2002;  36 303-304
    CrossrefPubMedGoogle Scholar
  • 9 Sugauchi F, Orito E, Ichida T. Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene.  J Virol . 2002;  76 5985-5992
    CrossrefPubMedGoogle Scholar
  • 10 Owiredu W K, Kramvis A, Kew M C. Hepatitis B virus DNA in serum of healthy black African adults positive for hepatitis B surface antibody alone: possible association with recombination between genotypes A and D.  J Med Virol . 2001;  64 441-454
    CrossrefPubMedGoogle Scholar
  • 11 Warren K S, Heeney J L, Swan R A, Heriyanto, Verschoor E J. A new group of hepadnaviruses naturally infecting orangutans (Pongo pygmaeus).  J Virol . 1999;  73 7860-7865
    PubMedGoogle Scholar
  • 12 Macdonald D, Holmes E, Lewis C, Simmonds P. Detection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): phylogenetic relationships with human and other primate genotypes.  J Virol . 2000;  74 4253-4257
    CrossrefPubMedGoogle Scholar
  • 13 Will H, Reiser W, Weimer T. Replication strategy of human hepatitis B virus.  J Virol . 1987;  61 904-911
    PubMedGoogle Scholar
  • 14 Carman W F, Zanetti A R, Karayiannis P. Vaccine-induced escape mutant of hepatitis B virus.  Lancet . 1990;  336 325-329
    CrossrefPubMedGoogle Scholar
  • 15 Okamoto H, Tsuda F, Sakugawa H. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes.  J Gen Virol . 1988;  69 2575-2583
    PubMedGoogle Scholar
  • 16 Milich D R, Thornton G B, Neurath A R. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen.  Science . 1985;  228 1195-1199
    PubMedGoogle Scholar
  • 17 Tron F, Degos F, Brechot C. Randomized dose range study of a recombinant hepatitis B vaccine produced in mammalian cells and containing the S and PreS2 sequences.  J Infect Dis . 1989;  160 199-204
    PubMedGoogle Scholar
  • 18 Bruss V, Hagelstein J, Gerhardt E, Galle P R. Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity.  Virology . 1996;  218 396-399
    CrossrefPubMedGoogle Scholar
  • 19 Milich D R, McLachlan A, Chisari F V, Kent S B, Thorton G B. Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg.  J Immunol . 1986;  137 315-322
    PubMedGoogle Scholar
  • 20 Chen H S, Kew M C, Hornbuckle W E. The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host.  J Virol . 1992;  66 5682-5684
    PubMedGoogle Scholar
  • 21 Hadziyannis S J, Vassilopoulos D. Hepatitis B e antigen- negative chronic hepatitis B.  Hepatology . 2001;  34 617-624
    CrossrefPubMedGoogle Scholar
  • 22 Milich D R, Jones J E, Hughes J L. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?.  Proc Natl Acad Sci U S A . 1990;  87 6599-6603
    PubMedGoogle Scholar
  • 23 Milich D R, McLachlan A, Moriarty A, Thornton G B. Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg.  J Immunol . 1987;  139 1223-1231
    PubMedGoogle Scholar
  • 24 Zoulim F, Seeger C. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase.  J Virol . 1994;  68 6-13
    PubMedGoogle Scholar
  • 25 Schlicht H J, Bartenschlager R, Schaller H. Biosynthesis and enzymatic functions of the hepadnaviral reverse transcriptase In: McLachlan A, ed. Molecular Biology of the Hepatitis B Viruses.  Boca Raton, FL: CRC Press 1991: 171-180
    Google Scholar
  • 26 Rehermann B, Fowler P, Sidney J. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.  J Exp Med . 1995;  181 1047-1058
    CrossrefPubMedGoogle Scholar
  • 27 Zoulim F, Saputelli J, Seeger C. Woodchuck hepatitis virus X protein is required for viral infection in vivo.  J Virol . 1994;  68 2026-2030
    PubMedGoogle Scholar
  • 28 Koik K. Hepatitis B virus HBx gene and hepatocarcinogenesis.  Intervirology . 1995;  38 134-142
    PubMedGoogle Scholar
  • 29 Rossne M T. Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator.  J Med Virol . 1992;  36 101-117
    PubMedGoogle Scholar
  • 30 Wang X W, Forrester K, Yeh H. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3.  Proc Natl Acad Sci U S A . 1994;  91 2230-2234
    CrossrefPubMedGoogle Scholar
  • 31 Truant R, Antunovic J, Greenblatt J, Prives C, Cromlish J A. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation.  J Virol . 1995;  69 1851-1859
    PubMedGoogle Scholar
  • 32 Wang X W, Gibson M K, Vermeulen W. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene.  Cancer Res . 1995;  55 6012-6016
    PubMedGoogle Scholar
  • 33 Huang J, Kwong J, Sun E-Y, Liang T. Proteasome complex as a potential cellular target of hepatitis H virus X protein.  J Virol . 1996;  70 5582-5591
    PubMedGoogle Scholar
  • 34 Hu Z, Zhang Z, Doo E. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex.  J Virol . 1999;  73 7231-7240
    PubMedGoogle Scholar
  • 35 Tur-Kaspa R, Shaul Y, Moore D D. The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer.  Virology . 1988;  167 630-633
    PubMedGoogle Scholar
  • 36 Freed E, Martin M. HIVs and their replication. In: Fields BNKD, Howley PM, Griffin BE, et al, eds. Fields Virology Philadelphia: Lippincott Williams & Wilkins 2001: 1971-2041
    Google Scholar
  • 37 Summers J, Mason W S. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate.  Cell . 1982;  29 403-415
    CrossrefPubMedGoogle Scholar
  • 38 Nassal M. Hepatitis B virus replication: novel roles for virus-host interactions.  Intervirology . 1999;  42 100-116
    CrossrefPubMedGoogle Scholar
  • 39 Seeger C, Mason W. Replication of the hepatitis virus genome. In: DePamphilis M, ed. DNA Replication in Eukaryotic Cells Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press 1996: 815-831
    Google Scholar
  • 40 Delaney IV E W, Locarnini S, Shaw T. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.  Antivir Chem Chemother . 2001;  12 1-35
    PubMedGoogle Scholar
  • 41 Neurath A R, Kent S B, Strick N, Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus.  Cell . 1986;  46 429-436
    CrossrefPubMedGoogle Scholar
  • 42 De Meyer S, Gong Z, Suwandhi W. Organ and species specificity of hepatitis B virus (HBV) infection: a review of literature with a special reference to preferential attachment of HBV to human hepatocytes.  J Viral Hepat . 1997;  4 145-153
    CrossrefPubMedGoogle Scholar
  • 43 Hild M, Weber O, Schaller H. Glucagon treatment interferes with an early step of duck hepatitis B virus infection.  J Virol . 1998;  72 2600-2606
    PubMedGoogle Scholar
  • 44 Bock C T, Schranz P, Schroder C H, Zentgraf H. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell.  Virus Genes . 1994;  8 215-229
    CrossrefPubMedGoogle Scholar
  • 45 Newbold J E, Xin H, Tencza M. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes.  J Virol . 1995;  69 3350-3357
    PubMedGoogle Scholar
  • 46 Park S G, Jung G. Human hepatitis B virus polymerase interacts with the molecular chaperonin Hsp60.  J Virol . 2001;  75 6962-6968
    CrossrefPubMedGoogle Scholar
  • 47 Lott L, Beames B, Notvall L, Lanford R E. Interaction between hepatitis B virus core protein and reverse transcriptase.  J Virol . 2000;  74 11479-11489
    CrossrefPubMedGoogle Scholar
  • 48 von Weizsacker F, Kock J, Weiland S. Cis-preferential recruitment of duck hepatitis B virus core protein to the RNA/polymerase preassembly complex.  Hepatology . 2002;  35 209-216
    CrossrefPubMedGoogle Scholar
  • 49 Staprans S, Loeb D D, Ganem D. Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA.  J Virol . 1991;  65 1255-1262
    PubMedGoogle Scholar
  • 50 Yang W, Mason W S, Summers J. Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virus-infected liver.  J Virol . 1996;  70 4567-4575
    PubMedGoogle Scholar
  • 51 Gerelsaikhan T, Tavis J E, Bruss V. Hepatitis B virus nucleocapsid envelopment does not occur without genomic DNA synthesis.  J Virol . 1996;  70 4269-4274
    PubMedGoogle Scholar
  • 52 Wei Y, Tavis J E, Ganem D. Relationship between viral DNA synthesis and virion envelopment in hepatitis B viruses.  J Virol . 1996;  70 6455-6458
    PubMedGoogle Scholar
  • 53 Bruss V, Thomssen R. Mapping a region of the large envelope protein required for hepatitis B virion maturation.  J Virol . 1994;  68 1643-1650
    PubMedGoogle Scholar
  • 54 Tuttleman J S, Pourcel C, Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells.  Cell . 1986;  47 451-460
    CrossrefPubMedGoogle Scholar
  • 55 Okamoto H, Imai M, Kametani M, Nakamura T, Mayumi M. Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission.  Jpn J Exp Med . 1987;  57 231-236
    PubMedGoogle Scholar
  • 56 Gunther S, Fischer L, Pult I, Sterneck M, Will H. Naturally occurring variants of hepatitis B virus.  Adv Virus Res . 1999;  52 25-137
    PubMedGoogle Scholar
  • 57 Zhang Y Y, Summers J. Enrichment of a precore-minus mutant of duck hepatitis B virus in experimental mixed infections.  J Virol . 1999;  73 3616-3622
    PubMedGoogle Scholar
  • 58 Zhang Y Y, Summers J. Low dynamic state of viral competition in a chronic avian hepadnavirus infection.  J Virol . 2000;  74 5257-5265
    CrossrefPubMedGoogle Scholar
  • 59 Doo E, Liang J T. Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection.  Gastroenterology . 2001;  120 1000-1008
    PubMedGoogle Scholar
  • 60 Seeger C, Mason W S. Hepatitis B virus biology.  Microbiol Mol Biol Rev . 2000;  64 51-68
    CrossrefPubMedGoogle Scholar
  • 61 Lok A S, Akarca U, Greene S. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal.  Proc Natl Acad Sci U S A . 1994;  91 4077-4081
    PubMedGoogle Scholar
  • 62 Liang T J, Hasegawa K, Rimon N, Wands J R, Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis.  N Engl J Med . 1991;  324 1705-1709
    PubMedGoogle Scholar
  • 63 Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis.  N Engl J Med . 1991;  324 1699-1704
    PubMedGoogle Scholar
  • 64 Okamoto H, Yotsumoto S, Akahane Y. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen.  J Virol . 1990;  64 1298-1303
    PubMedGoogle Scholar
  • 65 Hunt C M, McGill J M, Allen M I, Condreay L D. Clinical relevance of hepatitis B viral mutations.  Hepatology . 2000;  31 1037-1044
    CrossrefPubMedGoogle Scholar
  • 66 Akarca U S, Lok A S. Naturally occurring hepatitis B virus core gene mutations.  Hepatology . 1995;  22 50-60
    CrossrefPubMedGoogle Scholar
  • 67 Sirma H, Giannini C, Poussin K. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.  Oncogene . 1999;  18 4848-4859
    CrossrefPubMedGoogle Scholar
  • 68 Carman W F, Trautwein C, van Deursen J F. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis.  Hepatology . 1996;  24 489-493
    PubMedGoogle Scholar
  • 69 Stuyver L J, Locarnini S A, Lok A. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region.  Hepatology . 2001;  33 751-757
    CrossrefPubMedGoogle Scholar
  • 70 Melegari M, Scaglioni P, Wands J. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective.  Hepatology . 1998;  27 628-633
    CrossrefPubMedGoogle Scholar
  • 71 Liaw Y-F, Chien R-N, Yeh C-T, Tsai S-L, Chu C-M. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy.  Hepatology . 1999;  30 567-572
    CrossrefPubMedGoogle Scholar
  • 72 De Man A R, Bartholomeusz A, Niesters H GM, Zondervan P E, Locarnini S. The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B virus: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.  J Hepatol . 1998;  29 669-675
    CrossrefPubMedGoogle Scholar
  • 73 Locarnini S. Hepatitis B virus surface and polymerase gene variants: potential virological and clinical significance.  Hepatology . 1998;  27 294-297
    CrossrefPubMedGoogle Scholar
  • 74 Tillmann H L, Trautwein C, Bock T. Mutational analysis of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.  Hepatology . 1999;  30 244-256
    CrossrefPubMedGoogle Scholar
  • 75 Bock C, Tillmann H, Torresi J. HBV polymerase mutants with enhanced replication selected during lamivudine therapy result in sudden onset of liver failure.  Gastroenterology . 2002;  122 264-273
    PubMedGoogle Scholar
  • 76 Torresi J, Earnest-Silveira L, Deliyannis G. Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy.  Virology . 2002;  293 305-313
    CrossrefPubMedGoogle Scholar
  • 77 Thibault V, Aubron-Olivier C, Agut H, Katlama C. Primary infection with a lamivudine-resistant hepatitis B virus.  AIDS . 2002;  16 131-133
    CrossrefPubMedGoogle Scholar
      >